Activating public advertising for vaccines.

An advertising for vaccines has not been activated so far, but recently changed its policy focusing not on the awareness of the product through the professional journals so far but on the enlightenment of consumer for the diseases through the public media.

GSK recently filed the preliminary review to the KPMA for the public advertising of Fluarix, a flud vaccine and Havrix, an A viral hepati...